Literature DB >> 23379290

Effects of long-term ketamine administration on rat bladder protein levels: a proteomic investigation using two-dimensional difference gel electrophoresis system.

Di Gu1, Jun Huang, Zhengfei Shan, Youle Yin, Shaobin Zheng, Peng Wu.   

Abstract

OBJECTIVES: Long-term ketamine abuse can affect the urinary system, resulting in interstitial cystitis-like syndrome. However, its pathogenesis remains unclear. In the present study, a proteomic approach of two-dimensional difference gel electrophoresis followed by matrix-assisted laser desorption/ionization time-of-light mass spectrometry was carried out to investigate the potential disease-associated proteins in a rat model of ketamine-associated cystitis.
METHODS: Rats were randomly assigned to control, normal saline, low dose of ketamine (10 mg/kg) and high-dose of ketamine (50 mg/kg) groups with six rats in each group. The two experimental groups were given ketamine hydrochloride i.p. daily, whereas the normal saline group rats were treated with saline. After 16 weeks of treatment, all bladders were excised, and samples from normal saline and high dose of ketamine groups were resolved in two-dimensional difference gel electrophoresis. Differentially expressed spots were excised and identified by matrix-assisted laser desorption/ionization time-of-light mass spectrometry. Phosphoprotein and non-phosphoprotein purification, histopathology, immunohistochemistry, and western blot were carried out in all groups.
RESULTS: Histological study showed hyperplastic epithelium and inflammatory cells infiltration in the high dose of ketamine-treated rat bladders. Two-dimensional difference gel electrophoresis revealed 30 altered expressions between the normal saline and high dose of ketamine-treated group. Among these proteins, two upregulated and two downregulated protein spots were all identified as smooth muscle protein-22/transgelin. Immunohistochemical staining and western blot analysis showed that the expression of total transgelin had no significant difference between groups. However, the expression of phosphorylated transgelin in the low-dose and high dose of ketamine groups was increased, whereas the non-phosphorylated transgelin was decreased when compared with the normal saline group.
CONCLUSIONS: Long-term ketamine abuse induces phosphorylation of transgelin in the bladder wall, and this might play an important role in the pathogenesis of ketamine-associated cystitis.
© 2013 The Japanese Urological Association.

Entities:  

Keywords:  cystitis; ketamine; phosphorylation; protein transgelin; urinary bladder

Mesh:

Substances:

Year:  2013        PMID: 23379290     DOI: 10.1111/iju.12100

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  14 in total

Review 1.  Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment.

Authors:  Jason Ng; Leanna M W Lui; Joshua D Rosenblat; Kayla M Teopiz; Orly Lipsitz; Danielle S Cha; Jiaqi Xiong; Flora Nasri; Yena Lee; Kevin Kratiuk; Nelson B Rodrigues; Hartej Gill; Mehala Subramaniapillai; Rodrigo B Mansur; Roger Ho; Bing Cao; Roger S McIntyre
Journal:  Psychopharmacology (Berl)       Date:  2021-01-23       Impact factor: 4.530

2.  Chronic ketamine treatment-induced changes in contractility characteristics of the mouse detrusor.

Authors:  Hong Chai Tang; Wai Ping Lam; Xin Zhang; Ping-Chung Leung; David T Yew; Willmann Liang
Journal:  Int Urol Nephrol       Date:  2014-03-12       Impact factor: 2.370

3.  Silencing of soluble epoxide hydrolase 2 gene reduces H2O2-induced oxidative damage in rat intestinal epithelial IEC-6 cells via activating PI3K/Akt/GSK3β signaling pathway.

Authors:  Jun Li; Jihui Luo; Yang Zhang; Chunming Tang; Jiang Wang; Chaowu Chen
Journal:  Cytotechnology       Date:  2020-01-06       Impact factor: 2.058

4.  Urine metabolomics in rats after administration of ketamine.

Authors:  Congcong Wen; Meiling Zhang; Jianshe Ma; Lufeng Hu; Xianqin Wang; Guanyang Lin
Journal:  Drug Des Devel Ther       Date:  2015-02-03       Impact factor: 4.162

5.  Biological effect of ketamine in urothelial cell lines and global gene expression analysis in the bladders of ketamine‑injected mice.

Authors:  Cheng-Huang Shen; Shou-Tsung Wang; Ying-Ray Lee; Shiau-Yuan Liu; Yi-Zhen Li; Jiann-Der Wu; Yi-Ju Chen; Yi-Wen Liu
Journal:  Mol Med Rep       Date:  2014-10-30       Impact factor: 2.952

6.  Mesenchymal stem cells protect against the tissue fibrosis of ketamine-induced cystitis in rat bladder.

Authors:  Aram Kim; Hwan Yeul Yu; Jinbeom Heo; Miho Song; Jung-Hyun Shin; Jisun Lim; Soo-Jung Yoon; YongHwan Kim; Seungun Lee; Seong Who Kim; Wonil Oh; Soo Jin Choi; Dong-Myung Shin; Myung-Soo Choo
Journal:  Sci Rep       Date:  2016-08-02       Impact factor: 4.379

7.  Evaluation of urinary bladder fibrogenesis in a mouse model of long-term ketamine injection.

Authors:  Cheng-Huang Shen; Shou-Chieh Wang; Shou-Tsung Wang; Shu-Mei Lin; Jiann-Der Wu; Chang-Te Lin; Yi-Wen Liu
Journal:  Mol Med Rep       Date:  2016-07-07       Impact factor: 2.952

8.  Clinical significance of interleukin‑6 and inducible nitric oxide synthase in ketamine‑induced cystitis.

Authors:  Chi-Jung Huang; Fa-Kung Lee; Shao-Kuan Chen; Chih-Cheng Chien; Sheng-Tang Wu; Yen-Chieh Wang
Journal:  Int J Mol Med       Date:  2017-11-17       Impact factor: 4.101

9.  Ketamine‑induced bladder dysfunction is associated with extracellular matrix accumulation and impairment of calcium signaling in a mouse model.

Authors:  Cheng-Huang Shen; Shou-Tsung Wang; Shou-Chieh Wang; Shu-Mei Lin; Lei-Chen Lin; Yuan-Chang Dai; Yi-Wen Liu
Journal:  Mol Med Rep       Date:  2019-01-29       Impact factor: 2.952

10.  The Therapeutic Effect of Human Embryonic Stem Cell-Derived Multipotent Mesenchymal Stem Cells on Chemical-Induced Cystitis in Rats.

Authors:  Sang Wook Lee; Chae-Min Ryu; Jung-Hyun Shin; Daeheon Choi; Aram Kim; Hwan Yeul Yu; Ju-Young Han; Hye-Yeon Lee; Jisun Lim; Yong Hwan Kim; Jinbeom Heo; Seungun Lee; Hyein Ju; Sujin Kim; Ki-Sung Hong; Ji-Yeon Han; Miho Song; Hyung-Min Chung; Jun Ki Kim; Dong-Myung Shin; Myung-Soo Choo
Journal:  Int Neurourol J       Date:  2018-01-31       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.